20/20 BIOLABS, INC. (AIDX) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $122.51K; Additional Paid in CapitalUSD $38.43M; Retained Earnings (Accumulated Deficit)USD $-36.93M; Stockholders' Equity Attributable to ParentUSD $1.62M.
- 2026-03-31: Common Stock, Value, IssuedUSD $104.43K; Additional Paid in CapitalUSD $37.87M; Retained Earnings (Accumulated Deficit)USD $-35.42M; Stockholders' Equity Attributable to ParentUSD $2.55M.
- 2025-12-31: Common Stock, Value, IssuedUSD $54.42K; Additional Paid in CapitalUSD $33.13M; Retained Earnings (Accumulated Deficit)USD $-33.25M; Stockholders' Equity Attributable to ParentUSD $-19.23K.
- 2025-06-30: Common Stock, Value, IssuedUSD (m); Additional Paid in CapitalUSD (m); Retained Earnings (Accumulated Deficit)USD (m); Stockholders' Equity Attributable to ParentUSD $351.61K.
20/20 BIOLABS, INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature USD | Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings USD | Adjustments to Additional Paid in Capital, Warrant Issued USD |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $122.51K | $38.43M | $-36.93M | $1.62M | 3 month · $371.30K | (m) | 3 month · $121.66K | (m) |
| 2026-03-31 | $104.43K | $37.87M | $-35.42M | $2.55M | 3 month · $128.44K | 3 month · $1.00M | 3 month · $54.19K | (m) |
| 2025-12-31 | $54.42K | $33.13M | $-33.25M | $-19.23K | 12 month · $516.18K | (m) | (m) | 12 month · $16.91K |
| 2025-06-30 | (m) | (m) | (m) | $351.61K | 3 month · $129.65K | (m) | (m) | (m) |
| 2025-03-31 | (m) | (m) | (m) | $1.06M | 3 month · $129.65K | (m) | (m) | (m) |
| 2024-12-31 | $48.23K | $30.95M | $-29.51M | $1.51M | 12 month · $2.18M | (m) | (m) | (m) |
| 2023-12-31 | (m) | (m) | (m) | $4.29M | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGENOMICS INC (NEO) | United States | $2.514B | -35.96 |